Radnor Capital Management’s Boston Scientific BSX Stock Holding History

Radnor Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,852	Closed	-$242K	–	316
2026 Q1	$242K	Hold	3,852	–	–	0.04%	287
2025 Q4	$367K	Hold	3,852	–	–	0.05%	260
2025 Q3	$376K	Hold	3,852	–	–	0.06%	261
2025 Q2	$414K	Hold	3,852	–	–	0.07%	245
2025 Q1	$389K	Hold	3,852	–	–	0.07%	251
2024 Q4	$344K	Sell	3,852 -2,200	-36%	-$194K	0.06%	259
2024 Q3	$507K	Buy	+6,052	New	+$477K	0.08%	233
2024 Q2	–	Sell	-3,852	Closed	-$264K	–	172
2024 Q1	$264K	Hold	3,852	–	–	0.05%	281
2023 Q4	$223K	Hold	3,852	–	–	0.04%	300
2023 Q3	$203K	Buy	+3,852	New	+$202K	0.04%	293

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Radnor Capital Management's BSX Position: Q2 2026 in Review

Radnor Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,852 shares — an estimated $242K sold.

Radnor Capital Management first reported a position in BSX in Q3 2023 and held it in 10 quarters. The position peaked at $507K in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Radnor Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Radnor Capital Management sold 3,852 Boston Scientific shares in Q2 2026, an estimated $242K.
Radnor Capital Management first reported a position in Boston Scientific in Q3 2023 and held it in 10 quarters.
Radnor Capital Management's Boston Scientific position peaked at $507K in Q3 2024.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.